I have a question around aggregates.
You're estimating the net cost to the federal government—the net cost—and you say in one of the bullet points that all aggregate costs and projections would account for opportunities for savings.
I just want to confirm something. We know there's a significant spend already happening in the public sector for benefit programs that would no longer be required if a national pharmacare program were created. Also, there's a spend in the private sector to provide private drug plans to employers, which could be converted now and turned into the public system. Are those costs going to be identified and brought forward in the estimates of both offset costs for government and also potential sources of funds?